Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Injection for Rotator Cuff Tendinopathy Pain
NCT02967640Phase 3Completed
- Sponsor
- Helse Møre og Romsdal
- Start
- May 2018
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rotator cuff tendinopathy (RCT) comparing Ketalar with Placebo (2 arms). Primary endpoint: Pain at 30 minutes. Started May 2018; status: completed.
02
Drugs
ketamine
03
Conditions
rotator cuff tendinopathy (RCT)
Beyond the preview
Go deeper on NCT02967640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02967640.